Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Epidural Anesthesia and Survival in Lung Cancer Surgery
NCT02801409Completed
- Sponsor
- Peking University First Hospital
- Start
- May 2015
- Primary completion
- Nov 2017
- Countries
- 1
01
Overview
Randomised trial in non-small cell lung cancer (NSCLC) (2 arms), sponsored by Peking University First Hospital. Primary endpoint: Recurrence-free survival at 4 years. Started May 2015; status: completed.
02
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT02801409.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02801409.